Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 8
Submit an article Journal homepage
273
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients

Jianke Li Phenomix Corporation, San Diego, CA, USACorrespondence[email protected]
,
Kirsti Klemm Phenomix Corporation, San Diego, CA, USA
,
A. Marie O'Farrell Phenomix Corporation, San Diego, CA, USA
,
Hans-Peter Guler Phenomix Corporation, San Diego, CA, USA
,
Julie M. Cherrington Phenomix Corporation, San Diego, CA, USA
,
Sherwyn Schwartz Diabetes and Glandular Diseases Clinic, San Antonio, TX, USA
&
Teresa Boyea Phenomix Corporation, San Diego, CA, USA
 show all
Pages 2003-2010 | Accepted 04 May 2010, Published online: 29 Jun 2010

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Baptist Gallwitz. (2011) Small molecule dipeptidylpeptidase IV inhibitors under investigation for diabetes mellitus therapy. Expert Opinion on Investigational Drugs 20:6, pages 723-732.
Read now

Articles from other publishers (3)

Tore Bjerregaard Stage, Kim Brøsen & Mette Marie Hougaard Christensen. (2015) A Comprehensive Review of Drug–Drug Interactions with Metformin. Clinical Pharmacokinetics 54:8, pages 811-824.
Crossref
Chiranjib Chakraborty, Minna J. Hsu & Govindasamy Agoramoorthy. (2014) Understanding the Molecular Dynamics of Type-2 Diabetes Drug Target DPP-4 and its Interaction with Sitagliptin and Inhibitor Diprotin-A. Cell Biochemistry and Biophysics 70:2, pages 907-922.
Crossref
Jean-Francois Marier, Mohamad-Samer Mouksassi, Nathalie H. Gosselin & Jianke Li. (2014) Population pharmacokinetic analysis of dutogliptin, a selective dipeptidyl peptidase-4 inhibitor. Clinical Pharmacology in Drug Development 3:4, pages 297-304.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.